Kelly Brady, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 59 shares at $7.53 ($444) on 2026-05-18, disclosed to the SEC on 2026-05-19.
Open-market sale of $444 MCRB by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.